SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (166)6/6/2007 3:00:43 AM
From: tuck  Read Replies (2) of 285
 
The cardiovascular and renal drugs advisory committee meeting scheduled for August has been cancelled. So with an October PDUFA date and no meeting before then, it looks as though the vernakalant decision will be done without a committee. This perhaps derisks it a bit?

I might have to start my position again, even though I think the overall market is ripe for some fairly serious consolidation. Somebody remind me, when are we expecting those oral vernakalant results?

Edit: Never mind; oral 1235 results in Q4, yes? So I've got some time to re-enter, I'd think.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News